• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肺栓塞的临床表现与院内死亡:癌症是否有影响?

Clinical presentation and in-hospital death in acute pulmonary embolism: does cancer matter?

作者信息

Casazza Franco, Becattini Cecilia, Rulli Eliana, Pacchetti Ilaria, Floriani Irene, Biancardi Marco, Scardovi Angela Beatrice, Enea Iolanda, Bongarzoni Amedeo, Pignataro Luigi, Agnelli Giancarlo

机构信息

Cardiology Division, Ospedale San Carlo Borromeo, Milan, Italy.

Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Via G Dottori 1, Perugia, Italy.

出版信息

Intern Emerg Med. 2016 Sep;11(6):817-24. doi: 10.1007/s11739-016-1431-9. Epub 2016 Mar 29.

DOI:10.1007/s11739-016-1431-9
PMID:27023066
Abstract

Cancer is one of the most common risk factors for acute pulmonary embolism (PE), but only few studies report on the short-term outcome of patients with PE and a history of cancer. The aim of the study was to assess whether a cancer diagnosis affects the clinical presentation and short-term outcome in patients hospitalized for PE who were included in the Italian Pulmonary Embolism Registry. All-cause and PE-related in-hospital deaths were also analyzed. Out of 1702 patients, 451 (26.5 %) of patients had a diagnosis of cancer: cancer was known at presentation in 365, or diagnosed during the hospital stay for PE in 86 (19 % of cancer patients). Patients with and without cancer were similar concerning clinical status at presentation. Patients with cancer less commonly received thrombolytic therapy, and more often had an inferior vena cava filter inserted. Major or intracranial bleeding was not different between groups. In-hospital all-cause death occurred in 8.4 and 5.9 % of patients with and without cancer, respectively. At multivariate analysis, cancer (OR 2.24, 95 % CI 1.27-3.98; P = 0.006) was an independent predictor of in-hospital death. Clinical instability, PE recurrence, age ≥75 years, recent bed rest ≥3 days, but not cancer, were independent predictors of in-hospital death due to PE. Cancer seems a weaker predictor of all-cause in-hospital death compared to other factors; the mere presence of cancer, without other risk factors, leads to a probability of early death of 2 %. In patients with acute PE, cancer increases the probability of in-hospital all-cause death, but does not seem to affect the clinical presentation or the risk of in-hospital PE-related death.

摘要

癌症是急性肺栓塞(PE)最常见的危险因素之一,但仅有少数研究报道了有PE病史且患癌症患者的短期预后。本研究旨在评估癌症诊断是否会影响纳入意大利肺栓塞登记处的因PE住院患者的临床表现和短期预后。同时还分析了全因和与PE相关的住院死亡情况。在1702例患者中,451例(26.5%)被诊断患有癌症:365例在就诊时已知患有癌症,86例(占癌症患者的19%)在因PE住院期间被诊断出癌症。有癌症和无癌症患者在就诊时的临床状况相似。癌症患者较少接受溶栓治疗,且更常植入下腔静脉滤器。两组之间严重或颅内出血情况无差异。有癌症和无癌症患者的住院全因死亡率分别为8.4%和5.9%。多因素分析显示,癌症(比值比2.24,95%可信区间1.27 - 3.98;P = 0.006)是住院死亡的独立预测因素。临床不稳定、PE复发、年龄≥75岁、近期卧床休息≥3天,但癌症不是因PE导致住院死亡的独立预测因素。与其他因素相比,癌症似乎是全因住院死亡的较弱预测因素;仅患有癌症而无其他危险因素时,早期死亡概率为2%。在急性PE患者中,癌症会增加住院全因死亡的概率,但似乎不影响临床表现或住院PE相关死亡的风险。

相似文献

1
Clinical presentation and in-hospital death in acute pulmonary embolism: does cancer matter?急性肺栓塞的临床表现与院内死亡:癌症是否有影响?
Intern Emerg Med. 2016 Sep;11(6):817-24. doi: 10.1007/s11739-016-1431-9. Epub 2016 Mar 29.
2
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.静脉血栓栓塞和癌症患者的三个月死亡率和临床预测因素。RIETE 登记处的结果。
Thromb Res. 2013 Jan;131(1):24-30. doi: 10.1016/j.thromres.2012.10.007. Epub 2012 Nov 8.
3
Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER).心肌肌钙蛋白检测与简化的肺栓塞严重指数。瑞士静脉血栓栓塞登记处(SWIVTER)。
Thromb Haemost. 2011 Nov;106(5):978-84. doi: 10.1160/TH11-06-0371. Epub 2011 Aug 11.
4
Short-term clinical outcome after acute symptomatic pulmonary embolism.急性症状性肺栓塞后的短期临床结局
Thromb Haemost. 2008 Nov;100(5):937-42.
5
Short- and long-term mortality after pulmonary embolism in patients with and without cancer.癌症患者与非癌症患者肺栓塞后的短期和长期死亡率。
Vasc Med. 2018 Jun;23(3):261-266. doi: 10.1177/1358863X18754692. Epub 2018 Mar 9.
6
Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER).急性肺栓塞患者的临床特征和短期转归。意大利肺栓塞注册研究(IPER)。
Thromb Res. 2012 Dec;130(6):847-52. doi: 10.1016/j.thromres.2012.08.292. Epub 2012 Aug 24.
7
Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.下腔静脉滤器在有明显出血风险的急性有症状静脉血栓栓塞症患者中的生存效果。
J Am Coll Cardiol. 2014 Apr 29;63(16):1675-83. doi: 10.1016/j.jacc.2014.01.058. Epub 2014 Feb 25.
8
Which patients with venous thromboembolism are at risk for fatal pulmonary embolism?哪些静脉血栓栓塞患者有发生致命性肺栓塞的风险?
Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):604-5. doi: 10.1038/ncpcardio1308. Epub 2008 Aug 5.
9
Effectiveness of inferior vena cava filters on mortality as an adjuvant to antithrombotic therapy.下腔静脉滤器在辅助抗血栓治疗中的有效性对死亡率的影响。
Am J Med. 2015 Mar;128(3):312.e23-31. doi: 10.1016/j.amjmed.2014.10.034. Epub 2014 Nov 13.
10
Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study.癌症患者中无症状性肺栓塞的危险因素和临床转归:一项病例对照研究。
J Thromb Haemost. 2012 Oct;10(10):2032-8. doi: 10.1111/j.1538-7836.2012.04868.x.

引用本文的文献

1
Development and validation of a machine learning model for predicting venous thromboembolism complications following colorectal cancer surgery.用于预测结直肠癌手术后静脉血栓栓塞并发症的机器学习模型的开发与验证
Vis Comput Ind Biomed Art. 2025 Sep 12;8(1):22. doi: 10.1186/s42492-025-00204-y.
2
Acute pulmonary embolism and cancer: findings from the COPE study.急性肺栓塞与癌症:COPE 研究结果。
Clin Res Cardiol. 2024 Feb;113(2):288-300. doi: 10.1007/s00392-023-02323-z. Epub 2023 Nov 15.
3
Cardiogenic shock among cancer patients.

本文引用的文献

1
Vena cava filter use in cancer patients with acute venous thromboembolism in California.加利福尼亚州癌症合并急性静脉血栓栓塞患者腔静脉滤器的使用情况
Thromb Res. 2015 May;135(5):809-15. doi: 10.1016/j.thromres.2015.02.002. Epub 2015 Feb 7.
2
Cancer-associated thrombosis.癌症相关血栓形成
Hematology Am Soc Hematol Educ Program. 2013;2013:684-91. doi: 10.1182/asheducation-2013.1.684.
3
A prospective study on survival in cancer patients with and without venous thromboembolism.一项关于有和没有静脉血栓栓塞的癌症患者生存率的前瞻性研究。
癌症患者的心源性休克。
Front Cardiovasc Med. 2022 Aug 22;9:932400. doi: 10.3389/fcvm.2022.932400. eCollection 2022.
4
Controlling Nutritional Status Score Predicts In-Hospital Mortality in Acute Pulmonary Embolism.控制营养状况评分可预测急性肺栓塞患者的住院死亡率。
Med Princ Pract. 2022;31(5):439-444. doi: 10.1159/000525240. Epub 2022 May 25.
5
Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff?肺癌患者肺栓塞的流行病学和诊断:年龄调整 D-二聚体截断值是否有作用?
J Thromb Thrombolysis. 2020 May;49(4):572-577. doi: 10.1007/s11239-019-02003-8.
6
Saddle pulmonary embolism and in-hospital mortality in patients with cancer.癌症患者的鞍区肺栓塞与住院死亡率。
Int J Clin Oncol. 2019 Jun;24(6):727-730. doi: 10.1007/s10147-019-01406-0. Epub 2019 Feb 12.
7
Comorbid cancer and use of thrombolysis in acute pulmonary embolism.合并癌症与急性肺栓塞溶栓治疗的使用。
J Thromb Thrombolysis. 2019 Feb;47(2):324-327. doi: 10.1007/s11239-018-1772-5.
Intern Emerg Med. 2014 Aug;9(5):559-67. doi: 10.1007/s11739-013-0985-z. Epub 2013 Aug 14.
4
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.静脉血栓栓塞和癌症患者的三个月死亡率和临床预测因素。RIETE 登记处的结果。
Thromb Res. 2013 Jan;131(1):24-30. doi: 10.1016/j.thromres.2012.10.007. Epub 2012 Nov 8.
5
Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER).急性肺栓塞患者的临床特征和短期转归。意大利肺栓塞注册研究(IPER)。
Thromb Res. 2012 Dec;130(6):847-52. doi: 10.1016/j.thromres.2012.08.292. Epub 2012 Aug 24.
6
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.美国门诊高危癌症患者化疗期间静脉血栓栓塞症(VTE)的发生率及预测因素。
Cancer. 2013 Feb 1;119(3):648-55. doi: 10.1002/cncr.27772. Epub 2012 Aug 14.
7
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.急性有症状性肺栓塞合并活动性癌症的低危患者的临床预后模型。
Chest. 2013 Jan;143(1):138-145. doi: 10.1378/chest.12-0964.
8
Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool.癌症相关肺栓塞患者死亡率的多变量预测模型的建立和验证:POMPE-C 工具。
Thromb Res. 2012 May;129(5):e194-9. doi: 10.1016/j.thromres.2012.03.015. Epub 2012 Apr 3.
9
Outcomes considered most important by emergency physicians when determining disposition of patients with pulmonary embolism.在确定肺栓塞患者的处置方式时,急诊医生认为最重要的结果。
Int J Emerg Med. 2010 Oct 19;3(4):239-64. doi: 10.1007/s12245-010-0206-8.
10
Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry.癌症合并静脉血栓栓塞女性的 30 天死亡率。RIETE 注册研究的结果。
Thromb Res. 2011 Feb;127 Suppl 3:S1-4. doi: 10.1016/S0049-3848(11)00006-5.